GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Debt-to-Revenue

FibroBiologics (FibroBiologics) Debt-to-Revenue : N/A (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

FibroBiologics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.83 Mil. FibroBiologics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.28 Mil. FibroBiologics's annualized Revenue for the quarter that ended in Mar. 2024 was $0.00 Mil.


FibroBiologics Debt-to-Revenue Historical Data

The historical data trend for FibroBiologics's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Debt-to-Revenue Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Debt-to-Revenue
N/A N/A N/A

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of FibroBiologics's Debt-to-Revenue

For the Biotechnology subindustry, FibroBiologics's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FibroBiologics's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where FibroBiologics's Debt-to-Revenue falls into.



FibroBiologics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

FibroBiologics's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.362 + 1.385) / N/A
=N/A

FibroBiologics's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.831 + 1.277) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


FibroBiologics Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics (FibroBiologics) Business Description

Comparable Companies
Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines